Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral … – GlobeNewswire (press release)
|
Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral …
GlobeNewswire (press release) Oral mucosal immunotherapy (OMIT) uses a proprietary, specially formulated toothpaste to incorporate and stabilize allergenic proteins that are administered while a user brushes their teeth, delivering allergen-specific immunotherapy to the areas of … |
